SCHEMBL331307

SCHEMBL331307

[Au].c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.92

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.92
CYP3A4 P08684 1/20 0.92
ESR1 P03372 4/20 0.63
ESR2 Q92731 4/20 0.63
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
ALDH1A1 P00352 4/20 0.38
NPSR1 Q6W5P4 1/20 0.37
DRD1 P21728 2/20 0.35
TSHR P16473 4/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
LMNA P02545 2/20 0.33
CA12 O43570 1/20 0.33
GLA P06280 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA14 Q9ULX7 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28029401 1.00 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL28002945 0.96 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL27509645 0.96 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL28484904 0.96 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL2085135 0.96 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL5028587 0.96 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
Benzene SCHEMBL6890099 0.96 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL101 0.96 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL25384985 0.92 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL22445084 0.92 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120040524-A Lycium ruthenicum oligosaccharide derivative and preparation method and application thereof 河南中医药大学 2025-05-27 CN claimed
WO-2025039947-A1 SUPPORTED CATALYST HAVING AU@PT CORE-SHELL STRUCTURE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 中国科学院宁波材料技术与工程研究所 2025-02-27 WO claimed
CN-119500116-A Au@Pt core-shell structure supported catalyst and preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2025-02-25 CN claimed
CN-116174051-B Alpha, beta-unsaturated aldehyde or ketone hydrogenation method 中国科学院大连化学物理研究所 2024-12-31 CN claimed
CN-114570430-B Single-site gold-loaded covalent organic framework catalyst and preparation method and application thereof 浙江工业大学 2023-12-05 CN claimed
CN-112566919-A Conjugation method of biomolecule and new use of gold donor for biomolecule complex formation 雅盖隆大学 2021-03-26 CN claimed
CN-110523354-B Preparation method of microreactor containing immobilized catalyst 浙江大学 2021-01-19 CN claimed
CN-112010886-A Pyrroloxazine ring compound and preparation method thereof 复旦大学 2020-12-01 CN claimed
WO-2020036243-A1 METHOD FOR SYNTHESIZING THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, USING GOLD CATALYST, AND USE THEREFOR 한국해양과학기술원 2020-02-20 WO claimed
CN-110523354-A A kind of preparation method of the microreactor containing solid-carried catalyst UNIV ZHEJIANG 2019-12-03 CN claimed
CN-103372408-A Method for preparing metal-carbon composite of core-shell structure through simultaneous vaporization and metal-carbon composite of core-shell structure prepared thereby KOREA ENERGY RESEARCH INST 2013-10-30 CN claimed
CN-102398042-B Preparation method of nanometer gold bar mainly made of (200) crystal face NINGBO INST MAT TECH & ENG CAS 2013-02-13 CN claimed
CN-102690239-A Synthesis method of 1, 5-benzodiazepine derivative UNIV ZHEJIANG TECHNOLOGY 2012-09-26 CN claimed
CN-102398042-A Preparation method of nano gold rod with (200) crystal face as main component NINGBO INST MAT TECH & ENG CAS 2012-04-04 CN claimed
US-20120029241-A1 METHOD FOR PRODUCING CARBONYL COMPOUND, CATALYST, AND METHOD FOR PRODUCING CATALYST THE UNIVERSITY OF TOKYO (JP) 2012-02-02 US claimed
EP-2407446-A1 METHOD FOR PRODUCING CARBONYL COMPOUND, CATALYST, AND METHOD FOR PRODUCING CATALYST JX Nippon Oil & Energy Corporation (JP) 2012-01-18 EP claimed
EP-2152928-A1 MODIFIED MULTICHANNEL STRUCTURES Universität Hamburg (DE) 2010-02-17 EP claimed
US-7651674-B2 uniform particle size at the nanometer-scale level, selective and desired crystal structures, and various shapes; forming core-shell structure; useful to form a luminescent layer of an inorganic-organic hybrid electroluminescence device SAMSUNG ELECTRONICS CO., LTD. (KR) 2010-01-26 US claimed
WO-2008135542-A1 MODIFIED MULTICHANNEL STRUCTURES UNIVERSITÄT HAMBURG (DE) 2008-11-13 WO claimed
EP-1414832-B1 GOLD COMPOUNDS SIMULTANEOUSLY COORDINATED BY MONO- AND BIDENTATE PHOSPHINES HAVING ANTITUMORAL ACTIVITY CONSIGLIO NAZIONALE RICERCHE (IT) 2006-05-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029241-A1 METHOD FOR PRODUCING CARBONYL COMPOUND, CATALYST, AND METHOD FOR PRODUCING CATALYST PCCA, PPOX, COASY TDP1 4465/4885CYP3A4 163/4885ESR1 3005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.